Filing Details
- Accession Number:
- 0000315066-18-001774
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-05 12:27:23
- Reporting Period:
- 2018-04-03
- Accepted Time:
- 2018-04-05 12:27:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1622229 | Unum Therapeutics Inc. | UMRX | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
315066 | Fmr Llc | 245 Summer Street Boston MA 02210 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-04-03 | 349,462 | $0.00 | 349,462 | No | 4 | C | Indirect | F-Prime Capital Partners Healthcare Fund IV LP |
Common Stock | Acquisiton | 2018-04-03 | 8,601 | $0.00 | 358,063 | No | 4 | C | Indirect | F-Prime Capital Partners Healthcare Fund IV LP |
Common Stock | Acquisiton | 2018-04-03 | 94,052 | $12.00 | 452,115 | No | 4 | P | Indirect | F-Prime Capital Partners Healthcare Fund IV LP |
Common Stock | Acquisiton | 2018-04-03 | 1,890,701 | $0.00 | 1,890,701 | No | 4 | C | Indirect | Impresa Fund III Limited Partnership |
Common Stock | Acquisiton | 2018-04-03 | 46,534 | $0.00 | 1,937,235 | No | 4 | C | Indirect | Impresa Fund III Limited Partnership |
Common Stock | Acquisiton | 2018-04-03 | 22,682 | $0.00 | 22,682 | No | 4 | C | Indirect | F-Prime Capital Partners Healthcare Advisors Fund IV LP |
Common Stock | Acquisiton | 2018-04-03 | 558 | $0.00 | 23,240 | No | 4 | C | Indirect | F-Prime Capital Partners Healthcare Advisors Fund IV LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | F-Prime Capital Partners Healthcare Fund IV LP |
No | 4 | C | Indirect | F-Prime Capital Partners Healthcare Fund IV LP |
No | 4 | P | Indirect | F-Prime Capital Partners Healthcare Fund IV LP |
No | 4 | C | Indirect | Impresa Fund III Limited Partnership |
No | 4 | C | Indirect | Impresa Fund III Limited Partnership |
No | 4 | C | Indirect | F-Prime Capital Partners Healthcare Advisors Fund IV LP |
No | 4 | C | Indirect | F-Prime Capital Partners Healthcare Advisors Fund IV LP |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2018-04-03 | 548,702 | $0.00 | 349,462 | $0.00 |
Common Stock | Series A Preferred Stock | Disposition | 2018-04-03 | 2,968,650 | $0.00 | 1,890,701 | $0.00 |
Common Stock | Series A Preferred Stock | Disposition | 2018-04-03 | 35,614 | $0.00 | 22,682 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2018-04-03 | 13,505 | $0.00 | 8,601 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2018-04-03 | 73,065 | $0.00 | 46,534 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2018-04-03 | 877 | $0.00 | 558 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- On April 3, 2018, in connection with the completion of the issuer's initial public offering, each 1.5701314513884 shares of Series A and Series B Preferred Stock converted into 1 share of Common Stock.